Tobacco Cessation — Testing the Effectiveness of a Betel Nut Cessation Program
Citation(s)
33 Fiore M, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, Dorfman SF, Froelicher ES, Goldstein MG, Healton CG, Henderson PN, Heyman RB, Koh HK, Kottke TE, Lando HA, Mecklenburg RE, Mermelstein RJ, Mullen PD, Orleans CT, Robinson L, Stitzer ML, Tommasello AC, Villejo L, Wewers ME. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. 2008 update ed. Rockville, Md.: U.S. Dept. of Health and Human Services, Public Health Service; 2008. xvii, 256 p. p.
American Psychiatric Association Diagnostic and statistical manual of mental disorders : DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000. xxxvii, 943 p. p.
Benegal V, Rajkumar RP, Muralidharan K Does areca nut use lead to dependence? Drug Alcohol Depend. 2008 Sep 1;97(1-2):114-21. doi: 10.1016/j.drugalcdep.2008.03.016. Epub 2008 May 19.
Bhat SJ, Blank MD, Balster RL, Nichter M, Nichter M Areca nut dependence among chewers in a South Indian community who do not also use tobacco. Addiction. 2010 Jul;105(7):1303-10. doi: 10.1111/j.1360-0443.2010.02952.x.
Borrelli B The assessment, monitoring, and enhancement of treatment fidelity in public health clinical trials. J Public Health Dent. 2011 Winter;71 Suppl 1:S52-63.
Boucher BJ, Mannan N Metabolic effects of the consumption of Areca catechu. Addict Biol. 2002 Jan;7(1):103-10. Review.
Brandon TH, Baker TB The Smoking Consequences Questionnaire: the subjective expected utility of smoking in college students. Psychological Assessment. 1991;3:484-91.
Brown RA Intensive behavioral treatment. In: Abrams DB, editor. The tobacco dependence treatment handbook : a guide to best practices. New York: Guilford Press; 2003. p. 118-77.
Brown, R A. (2003). Intensive behavioral treatment. In D. B. Abrams (Ed.), The tobacco dependence treatment handbook : a guide to best practices (pp. 118-177). New York: Guilford Press.
Chandra PS, Carey MP, Carey KB, Jairam KR Prevalence and correlates of areca nut use among psychiatric patients in India. Drug Alcohol Depend. 2003 Apr 1;69(3):311-6.
Chu NS Neurological aspects of areca and betel chewing. Addict Biol. 2002 Jan;7(1):111-4. Review.
Cohen J Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, N.J.: L. Erlbaum Associates; 1988. xxi, 567 p. p.
Franke AA, Lai JF, Kawamoto CT, Pokhrel P, Herzog TA University of Hawai'i Cancer Center connection: Areca (betel) nut consumption: an underappreciated cause of cancer. Hawaii J Med Public Health. 2014 Dec;73(12):400-3. Review.
Franke AA, Mendez AJ, Lai JF, Arat-Cabading C, Li X, Custer LJ Composition of betel specific chemicals in saliva during betel chewing for the identification of biomarkers. Food Chem Toxicol. 2015 Jun;80:241-246. doi: 10.1016/j.fct.2015.03.012. Epub 2015 Mar 19.
Glover E, Wang M, WGlover P Development of a high school smokeless tobacco cessation manual. Health Values: The Journal of Health Behavior, Education & Promotion. 1994;18(2):1-7.
Gupta B, Johnson NW Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One. 2014 Nov 20;9(11):e113385. doi: 10.1371/journal.pone.0113385. eCollection 2014. Review.
Gupta PC, Ray CS Epidemiology of betel quid usage. Ann Acad Med Singap. 2004 Jul;33(4 Suppl):31-6. Review.
Herzog TA, Pokhrel P Ethnic differences in smoking rate, nicotine dependence, and cessation-related variables among adult smokers in Hawaii. J Community Health. 2012 Dec;37(6):1226-33. doi: 10.1007/s10900-012-9558-8.
Herzog TA Analyzing the transtheoretical model using the framework of Weinstein, Rothman, and Sutton (1998): the example of smoking cessation. Health Psychol. 2008 Sep;27(5):548-56. doi: 10.1037/0278-6133.27.5.548.
Jeng JH, Chang MC, Hahn LJ Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 2001 Sep;37(6):477-92. Review.
Lee CH, Ko YC, Huang HL, Chao YY, Tsai CC, Shieh TY, Lin LM The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer. 2003 Feb 10;88(3):366-72.
Lee CY, Chang CS, Shieh TY, Chang YY Development and validation of a self-rating scale for betel quid chewers based on a male-prisoner population in Taiwan: the Betel Quid Dependence Scale. Drug Alcohol Depend. 2012 Feb 1;121(1-2):18-22. doi: 10.1016/j.drugalcdep.2011.07.027. Epub 2011 Sep 28.
Nair U, Bartsch H, Nair J Alert for an epidemic of oral cancer due to use of the betel quid substitutes gutkha and pan masala: a review of agents and causative mechanisms. Mutagenesis. 2004 Jul;19(4):251-62. Review.
Norton SA Betel: consumption and consequences. J Am Acad Dermatol. 1998 Jan;38(1):81-8. Review.
Oakley E, Demaine L, Warnakulasuriya S Areca (betel) nut chewing habit among high-school children in the Commonwealth of the Northern Mariana Islands (Micronesia). Bull World Health Organ. 2005 Sep;83(9):656-60. Epub 2005 Sep 30.
Paulino Y Betel nut chewing in Micronesian populations. Achievement Rewards for College Scientists Selection Meeting; 2008; Honolulu, HI.
Paulino YC, Hurwitz EL Making the case for clearly defining tobacco use in areca (betel) nut chewers. American Public Health Association Annual Meeting; 2014; New Orleans, LA
Perkins KA, Conklin CA, Levine MD Cognitive-behavioral therapy for smoking cessation : a practical guidebook to the most effective treatments. New York: Routledge; 2008. xxii, 258 p. p.
Pindborg JJ, Sirsat SM Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol. 1966 Dec;22(6):764-79.
Shah SM, Merchant AT, Luby SP, Chotani RA Addicted schoolchildren: prevalence and characteristics of areca nut chewers among primary school children in Karachi, Pakistan. J Paediatr Child Health. 2002 Oct;38(5):507-10.
Stead LF, Lancaster T Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD001007. Review. Update in: Cochrane Database Syst Rev. 2017 Mar 31;3:CD001007.
Thomas S, Kearsley J Betel quid and oral cancer: a review. Eur J Cancer B Oral Oncol. 1993 Oct;29B(4):251-5. Review.
Uncangco, A A., Badowski, G., David, A. M., Ehlert, M. B., Haddock, R. L., & Paulino, Y. C. (2012). First Guam BRFSS Report 2017-2010. Retrieved from Mangilao, GU:
Williams S, Arheart KL, WKiesges R A smokeless tobacco cessation program for postsecondary students. Health Values: The Journal of Health Behavior, Education & Promotion. 1995;19(3):1-9.
Winstock A Areca nut-abuse liability, dependence and public health. Addict Biol. 2002 Jan;7(1):133-8.
World Health Organization (2012). Review of areca (betel) nut and tobacco use in the Pacific: a technical report. Geneva: World Health Organization.
World Health Organization The ICD-10 classification of mental and behavioural disorders : clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992. xii, 362 p. p.
NIH-NCI U54 University of Guam/Cancer Center of Hawaii Partnership Full Project II: The Betel Nut Intervention Trial
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.